ARTICLE | Clinical News
KOS-862 epothilone D: Phase II discontinued
June 28, 2004 7:00 AM UTC
KOSN and ROCZ stopped a Phase II trial of KOS-862 in an undisclosed number of patients to treat colorectal cancer after seeing unexpected cumulative toxicities in patients previously treated with oxal...